Do Visa and Mastercard Need a Coronavirus Vaccine to Win in 2021?

Visa (NYSE: V) and Mastercard (NYSE: MA) have held up better than most other financial sector stocks in 2020, and this certainly makes sense as the companies make money from consumer spending, regardless of whether sales come in-store or through e-commerce. In fact, the trend toward e-commerce during the pandemic has been somewhat of a tailwind, as online sales are all cashless. 

But what about in the post-pandemic world? In this Nov. 25 Fool Live video clip, Fool.com contributors Matt Frankel, CFP, and Brian Feroldi take a look at whether Visa and Mastercard are so-called "reopening" stocks, or if they don't need a vaccine to thrive.

Continue reading

Source Fool.com